Safety and Tolerability of Ferric Carboxymaltose (FCM) Versus Iron Dextran in Treating Iron Deficiency Anemia

NCT00704028 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

161

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia

Interventions

DRUG: Ferric Carboxymaltose
DRUG: Iron Dextran

Sponsor

American Regent, Inc.